Комбинированные оральные контрацептивы и депрессивные расстройства

1. Манухин И.Б., Геворкян Е.И., Манухина Е.И. Гинекологическая эндокринология. Клинические лекции. 5-е изд. М.: ГЭОТАР-Медиа; 2024. 304 с.
2. Савельева Г.М., Сухих Г.Т., Манухин И.Б., ред. Гинекология. Национальное руководство. Краткое издание. М.: ГЭОТАР-Медиа; 2013. 704 с.
3. Кузнецова И.В., Бурчаков Д.И. Управление менструальным циклом – новая концепция применения комбинированных оральных контрацептивов. Акушерство и гинекология. 2016; 10: 132-7. [Kuznetsova I.V., Burchakov D.I. Control of the menstrual cycle: A new concept of the use of combined oral contraceptives. Obstetrics and Gynecology. 2016; (10): 132-7.
4. (in Russian)]. https://dx.doi.org/10.18565/aig.2016.10.132-37.
5. Коновалов В.А., Кузнецова И.В. Комбинированная оральная контрацепция как метод сохранения репродуктивного здоровья. Акушерство и гинекология. 2014; 12: 42-7.
6. Jaafar K., Nabhan E., Daoud R., Nasser Z. Prevalence of anxiety and depression among Lebanese women using oral contraceptives: a cross-sectional study. BMC Womens Health. 2024; 24(1): 47. https://dx.doi/org/10.1186/s12905-024-02897-4.
7. Hall K.S., Moreau C., Trussell J., Barber J. Role of young women's depression and stress symptoms in their weekly use and nonuse of contraceptive methods. J. Adolesc. Health. 2013; 53(2): 241-8. https://dx.doi/org/10.1016/j.jadohealth.2013.02.009.
8. Gingnell M., Engman J., Frick A., Moby L., Wikström J., Fredrikson M. et al. Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill – a double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive. Psychoneuroendocrinology. 2013; 38(7): 1133-44. https://dx.doi/org/10.1016/j.psyneuen.2012.11.006.
9. Hall K.S., O'Connell K.W., Rickert V.I., Reame N., Westhoff C. Influence of depressed mood and psychological stress symptoms on perceived oral contraceptive side effects and discontinuation in young minority women. Contraception. 2012; 86(5): 518-25. https://dx.doi/org/10.1016/j.contraception.2012.04.010.
10. Hall K.S., Steinberg J.R., Cwiak C.A., Allen R.H., Marcus S.M. Contraception and mental health: a commentary on the evidence and principles for practice. Am. J. Obstet. Gynecol. 2015; 212(6): 740-6. https://dx.doi/org/10.1016/j.ajog.2014.12.010.
11. Toffol E., Heikinheimo O., Koponen P., Luoto R., Partonen T. Further evidence for lack of negative associations between hormonal contraception and mental health. Contraception. 2012; 86: 470-80. https://dx.doi/org/10.1016/j.contraception.2012.02.014.
12. Keyes K.M., Cheslack-Postava K., Westhoff C., Heim C.M., Haloossim M., Walsh K. et al. Association of hormonal contraceptive use with reduced levels of depressive symptoms: A national study of sexually active women in the United States. Am. J. Epidemiol. 2013; 178: 1378-88. https://dx.doi/org/10.1093/aje/kwt188.
13. de Wit A.E., Booij S.H., Giltay E.J., Joffe H., Schoevers R.A., Oldehinkel A.J. Association of use of oral contraceptives with depressive symptoms among adolescents and young women. JAMA Psychiatry. 2020; 77(1): 52-9. https://dx.doi/org/10.1001/jamapsychiatry.2019.2838.
14. Toffoletto S., Lanzenberger R., Gingnell M., Sundström-Poromaa I., Comasco E. Emotional and cognitive functional imaging of estrogen and progesterone effects in the female human brain: a systematic review. Psychoneuroendocrinology. 2014; 50: 28-52. https://dx.doi/org/10.1016/j.psyneuen.2014.07.025.
15. Del Río J.P., Alliende M.I., Molina N., Serrano F.G., Molina S., Vigil P. Steroid hormones and their action in women's brains: the importance of hormonal balance. Front. Public Health. 2018; 6: 141. https://dx.doi/org/10.3389/fpubh.2018.00141.
16. Mu E., Kulkarni J. Hormonal contraception and mood disorders. Aust. Prescr. 2022; 45(3): 75-9. https://dx.doi/org/10.18773/austprescr.2022.025.
17. Li R., Singh M. Sex differences in cognitive impairment and Alzheimer’s disease. Front. Neuroendocrinol. 2014; 35(3): 385-403. https://dx.doi/org/10.1016/j.yfrne.2014.01.002.
18. Rettberg J.R., Yao J., Brinton R.D. Estrogen: a master regulator of bioenergetic systems in the brain and body. Front. Neuroendocrinol. 2014; 35(1): 8-30. https://dx.doi/org/10.1016/j.yfrne.2013.08.001.
19. Arevalo M.A., Azcoitia I., Garcia-Segura L.M. The neuroprotective actions of oestradiol and oestrogen receptors. Nat. Rev. Neurosci. 2014; 16(1): 17-29. https://dx.doi/org/10.1038/nrn3856.
20. Schumacher M., Mattern С., Ghoumari A., Oudinet J.P., Liere P., Labombarda F. et al. Revisiting the roles of progesterone and allopregnanolone in the nervous system: resurgence of the progesterone receptors. Prog. Neurobiol. 2014; 113: 6-39. https://dx.doi/org/10.1016/j.pneurobio.2013.09.004.
21. Skovlund C.W., Mørch L.S., Kessing L.V., Lidegaard Ø. Association of hormonal contraception with depression. JAMA Psychiatry. 2016; 73(11): 1154-62. https://dx.doi/org/10.1001/jamapsychiatry.2016.2387.
22. Козлов П.В. Регуляция женского сексуального поведения и возможности медикаментозной терапии. Медицинский совет. 2023; 17(5): 15-20.
23. Mukherjee J., Cardarelli R.A., Cantaut-Belarif Y., Deeb T.Z., Srivastava D.P., Tyagarajan S.K. et al. Estradiol modulates the efficacy of synaptic inhibition by decreasing the dwell time of GABA receptors at inhibitory synapses. Proc. Natl. Acad. Sci. U. S. A. 2017; 114(44): 11763-8. https://dx.doi/org/10.1073/pnas.1705075114.
24. Каркусова М.Д. Биологические эффекты серотонина (обзорная статья). Вестник новых медицинских технологий. 2022; 16(6): 133-9.
25. Паневин Т.С., Бобкова А.О., Каратеев А.Е, Зоткин Е.Г. Дефицит эндогенных эстрогенов и развитие хронической скелетно-мышечной боли. Терапевтический архив. 2022; 94(5): 683-8.
26. Карпова И.В., Прошин С.Н., Глушаков Р.И., Михеев В.В., Бычков Е.Р. Половые различия по содержанию моноаминов в симметричных структурах мозга мышей линии С3 Н-А. Педиатр. 2014; 5(2): 56-64.
27. Andréen L., Nyberg S., Turkmen S., van Wingen G., Fernández G., Bäckström T. Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators. Psychoneuroendocrinology. 2009; 34(8): 1121-32. https://dx.doi/org/10.1016/j.psyneuen.2009.02.003.
28. Hausmann M., Güntürkün O. Steroid fluctuations modify functional cerebral asymmetries: the hypothesis of progesterone-mediated interhemispheric decoupling. Neuropsychologia. 2000; 38(10): 1362-74. https://dx.doi/org/10.1016/S0028-3932(00)00045-2.
29. Bengtsdotter H., Lundin C., Gemzell Danielsson K., Bixo M., Baumgart J., Marions L. et al. Ongoing or previous mental disorders predispose to adverse mood reporting during combined oral contraceptive use. Eur. J. Contracept. Reprod. Health Care. 2018; 23(1): 45-51. https://dx.doi/org/10.1080/13625187.2017.1422239.
30. Segebladh B., Borgström A., Odlind V., Bixo M., Sundström-Poromaa I. Prevalence of psychiatric disorders and premenstrual dysphoric symptoms in patients with experience of adverse mood during treatment with combined oral contraceptives. Contraception. 2009; 79(1): 50-5. https://dx.doi/org/10.1016/j.contraception.2008.08.001.
31. Yusuf A.M., Warsame M.O., Gedi S., Abdullahi N.A., Ahmed D.I. Prevalence of depression among women using hormonal contraceptives in Mogadishu, Somalia: a cross-sectional study. Open Access J. Contracept. 2024; 15: 89-98. https://dx.doi/org/10.2147/OAJC.S444545.
32. Déa C.A., Moreira E.C.H., Zamboti C.L. Sexual function, quality of life, anxiety, and depression in women of reproductive age using hormonal, nonhormonal, and no contraceptive methods. J. Sex. Med. 2024; 21(8): 683-90. https://dx.doi/org/10.1093/jsxmed/qdae060.
33. Lundin C., Wikman A., Lampa E., Bixo M., Gemzell-Danielsson K., Wikman P. et al. There is no association between combined oral hormonal contraceptives and depression: a Swedish register-based cohort study. BJOG. 2022; 129(6): 917-25. https://dx.doi/org/10.1111/1471-0528.17028.
34. McKetta S., Keyes K.M. Oral contraceptive use and depression among adolescents. Ann. Epidemiol. 2019; 29: 46-51. https://dx.doi/org/10.1016/j.annepidem.2018.10.002.
35. Johansson T., Vinther Larsen S., Bui M., Ek W.E., Karlsson T., Johansson Å. Population-based cohort study of oral contraceptive use and risk of depression. Epidemiol. Psychiatr. Sci. 2023; 32: e39. https://dx.doi/org/10.1017/S2045796023000525.
36. Anderl C., Li G., Chen F.S. Oral contraceptive use in adolescence predicts lasting vulnerability to depression in adulthood. J. Child. Psychol. Psychiatry. 2020; 61(2): 148-56. https://dx.doi/org/10.1111/jcpp.13115.

Поступила 12.12.2024

Принята в печать 21.03.2025